On the stock market since 2021, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
No real growth (2% a year). Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Sales run at $392.7M a year. A small number, but proof the product has real buyers.
A loss of $51.3M against $392.7M in annual sales.
The stock sits at $0.90. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
On our five-subject report card, GPCOR sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: GPCOR is a high-risk stock — not yet profitable, and its future rides on its product catching on.